PATH vs VERO · P/E 19, rev $1.61B vs rev $64.8M
Uipath Inc (PATH) versus Venus Concept Inc (VERO) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Venus Concept Inc (VERO) is a medical devices company listed on NASDAQ.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported VERO revenue for 2024-12-31 was $64.8M. Net income was -$47.0M. Revenue was down 15.1% from 2023-12-31 to 2024-12-31. VERO currently screens at market cap $578.2K.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. VERO currently screens at market cap $578.2K.
Not investment advice. Open the PATH and VERO stock pages for the full models.
Not investment advice.